Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2025, Vol. 30 ›› Issue (4): 517-525.doi: 10.12092/j.issn.1009-2501.2025.04.010

Previous Articles     Next Articles

Research progress of epigenetics in the pathogenesis of depression

ZHANG Yao1, ZOU Manshu1,3, HAN Yuanshan2,3, WANG Yuhong1,3   

  1. 1Technology Innovation Center, Hunan University of Chinese Medicine, Changsha 410208, Hunan, China; 2The First Affiliated Hospital of Hunan University of Chinese Medicine, Changsha 410007, Hunan, China; 3Hunan Provincial Key Laboratory of Prevention and Treatment of Depressive Diseases with Traditional Chinese Medicine, Changsha 410208, Hunan, China
  • Received:2024-06-06 Revised:2024-08-15 Online:2025-04-26 Published:2025-04-09

Abstract:

Depression is a mental disease with increasing prevalence worldwide, which seriously endangers human health with high disability rate and high suicide rate. Epigenetics is an emerging genetic theory in the 21st century. Its main research content is to regulate the process of gene transcription or translation and affect its function and characteristics without changing the DNA sequence. These include DNA methylation, histone modification, chromatin remodeling and non-coding RNA regulation. The nervous system is susceptible to changes in the activity of epigenetic modifiers, and an increasing number of studies have shown that genetics and environment play an important role in the development of depression. This review will focus on the epigenetic mechanisms of depression.

Key words: depression, epigenetics, DNA methylation, histone modification, noncoding RNA regulation, chromatin remodeling

CLC Number: